Mitochondria antioxidant protection against cardiovascular dysfunction programmed by early-onset gestational hypoxia

Area of Science:

• Cardiovascular Science
• Developmental Biology
• Mitochondrial Medicine

Background:

• Mitochondrial oxidative stress during fetal development, caused by chronic hypoxia, elevates cardiovascular risk in adult offspring.
• Gestational hypoxia programs offspring for increased susceptibility to cardiovascular dysfunction later in life.

Purpose of the Study:

• To investigate the efficacy of the mitochondria-targeted antioxidant MitoQ in preventing cardiovascular dysfunction in adult rat offspring exposed to gestational hypoxia.
• To elucidate the molecular mechanisms underlying the protective effects of MitoQ against hypoxia-induced cardiovascular programming.

Main Methods:

• Rats underwent normoxic or hypoxic pregnancies with or without maternal MitoQ supplementation.
• Cardiovascular function was assessed in vivo and ex vivo in adult male offspring.
• Gene expression analysis of antioxidant systems, β-adrenergic signaling, and calcium handling was performed in fetal and adult offspring tissues.

Main Results:

• Maternal MitoQ administration during hypoxic pregnancy protected offspring against adverse cardiovascular outcomes.
• Protection included reduced α1-adrenergic reactivity, improved peripheral vascular function, and normalized cardiac contractility and diastolic function.
• MitoQ inhibited fetal Nfe2l2-mediated oxidative stress and preserved calcium handling in fetal and adult hearts.

Conclusions:

• MitoQ effectively buffers mitochondrial stress and prevents programmed cardiovascular disease in offspring of hypoxic pregnancies.
• The protective effects are linked to the inhibition of oxidative damage and preservation of calcium regulatory mechanisms.
• Targeting mitochondrial dysfunction during development offers a promising strategy for preventing adult cardiovascular disease.